VALN News and Press, Valneva SE From 08/11/22

Valneva ( NASDAQ: VALN ) ( OTCPK:INRLF ) ( OTC:VNVLF ) reduced its FY22 revenue outlook citing reduced demand for its COVID vaccine from the EU member states. COVID-19 vaccine sales in H1 were €3.8M. However, Valneva recorded an operating loss of...

Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study...

Valneva is a specialty vaccines company with an ongoing travelers vaccine business. Two major catalysts are around the corner: a BLA for chikungunya vaccine and a Phase 3 trial for the world’s only Lyme vaccine candidate. The company is trading near the low end of its 52-we...

We are revisiting Dynavax Technologies after this vaccine concern just posted robust quarterly results that easily exceeded expectations. The company continues to gain market share with its Hepatitis B vaccine and is seeing huge revenue growth from its Covid-19 efforts. What's nex...

The European Commission announced an agreement with Valneva ( NASDAQ: VALN ) ( OTCPK:INRLF ) ( OTC:VNVLF ) on Wednesday that would sharply reduce the French biotech’s COVID-19 vaccine deliveries to the region this year. In late June, the commission approved ...

The health authorities in the EU have recommended a second COVID-19 booster shot for those aged 60 – 79 and medically vulnerable people who are at high risk of severe disease, the European Medicines Agency (EMA) said in a statement on Monday. In April, The European Centre for...

Pure play COVID-19 vaccine makers closed the 1H 2022 as some of the worst performers in the beaten-down biotech space amid concerns over how the group, once a pandemic favorite, could sustain growth as COVID impact wanes. The selloff, worse than the ~33% decline among biotech stocks...

Gainers: Agile Therapeutics (AGRX) +81%. Kezar Life Sciences (KZR) +75%. Decibel Therapeutics (DBTX) +21%. Sutro Biopharma (STRO) +16%. Bellerophon Therapeutics (BLPH) +11%. Losers: Scholar Rock (SRRK) -11%. NGM Biopharmaceuticals (NGM)&#...

French biotech Valneva (NASDAQ:VALN) announced on Friday that the European Commission (EC) granted marketing authorization for its inactivated whole-virus COVID-19 vaccine, VLA2001 for primary vaccination in those aged 18 – 50. The approval for VLA2001 marks the first time the regulato...

Gainers: Anebulo Pharmaceuticals (ANEB) +32%. Tenon Medical (TNON) +19%. PolarityTE (PTE) +14%. TRACON Pharmaceuticals (TCON) +14%. Bausch Health (BHC) +13%. Losers: BioSig Technologies (BSGM) -26%. Rigel Pharmaceuticals (RIGL) -8%. Valneva (VALN) ...